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Commentary
Multifactorial Carcinogenesis:
Implications for Regulatory Practice
by John Higginson*
The last decade has seen increased recognition of
the complexities of carcinogenesis, with significant
implications for cancer control and prevention. No
attempt will be made in the present paper to
discuss in depth the molecular and biological nature
of multistage carcinogenesis, as these aspects are
adequately covered by other papers. Rational
regulation, however, will depend on some un-
derstanding of their mechanisms.
Early attempts by authorities to regulate and
control disease were directed to communicable dis-
eases such as smallpox, plague, leprosy, etc. In view
of the very inadequate understanding of basic
mechanisms, regulations were essentially pragma-
tic, being based on empirical observation. Nonethe-
less the successful control of these diseases has had
a major impact on public health policy and scientific
attitudes to the prevention of chronic disease, in-
cluding cancer, by regulation of defined hazards.
These attitudes were reinforced by the successes in
cancer prevention and control through the iden-
tification of major occupational and drug hazards,
and of the danger of such cultural habits as
cigarette smoking, betel chewing and ethanol
ingestion. Today, effective public health regulations
and guidelines have been promulgated for a number
of defined risks in many states. Accordingly, cancer
control has tended to be considered only in the
context of a single predominant initiating factor,
e.g., 2-naphthylamine, although the role of promo-
tion in cigarette smoking in lung cancer had already
been emphasized in the early 1950s (1).
It had long been clear, however, that many hu-
man cancers could not readily be ascribed to a
single predominant carcinogenic stimulus and that
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many other factors were involved, including diet
and behavioral and cultural patterns (2). Thus,
observations in the South African Bantu demon-
strated that cancer patterns differed very signifi-
cantly from those within industrial countries, and
that many cancers could not all be readily explained
by then current hypotheses. While confirming the
influence of environment as a total concept, it was
emphasized that "way of life" was also involved (3).
Nonetheless, although well documented by the
1940s (4), the concept of two-stage or multistage car-
cinogenesis tended to be neglected. More recently,
the importance of modulating stimuli has received
attention as analytical studies in humans have dem-
onstrated an association with certain "carcinogenic
risk factors" related to behavior and diet. This is a
convenient term for many lifestyle-associated risks.
Such risk factors are believed to reflect modulating
stimuli which effect not only initiation but also
promotion and inhibition (5-7). These are now being
investigated as described by others at this meeting.
The question therefore arises as to what extent
the principles adopted for control of well defined
carcinogenic hazards, chemical or physical, are
equally effective for the prevention of those cancers
possibly related to the interactions of the many
exogenous and endogenous factors involving
initiation, cocarcinogenesis, promotion, progression,
inhibition and modulation. This is an area in which
there still remains considerable confusion as to
terminology, since the basic mechanisms are poorly
understood at the molecular level. Further, classical
epidemiology and experimental approaches do not
offer satisfactory possibilities for pragmatic preven-
tion, at least in theory. For convenience, the present
discussion will use the terms "initiation" and "pro-
motion" with the connotation developed from the
mouse two-stage model, recognizing their inade-
quacies in biological terms, since this model no
longer adequately reflects current views on carcino-
genic mechanisms.J. HIGGINSON
Aims of Legislation and
Regulation
There is an extensive literature on this subject,
and some of the problems have been recently
summarized by Campbell (8). Fredrickson (9) has
described the difficulties in reaching
a consensus even among scientists, especially where
they are uncertain as to degree of risk and mecha-
nisms. In general, while the objectives of certain
legislative regulations may appear obvious and
based on common sense, implementation may give
rise to scientific and socioeconomic problems of
enormous complexity. Ideally, regulation should
meet the following requirements.
Regulation should be effective and efficient, lead-
ing to reduction in the hazard. It is important,
moreover, that its effectiveness should be clearly
perceived. This requires that the degree of risk can
be measured and defined, and that effect can be
demonstrated. Unfortunately, the latter may not be
practical where the risk is very low or where only
the potential of risk exists.
If possible, regulation should be consistent and
not arbitrary or subjective. This requires conform-
ity with widely recognized political and scientific
norms. A consensus may not exist with ill-defined
generic risks as compared to defined and measur-
able risks. Thus, while there is no real conflict
between the scientific data and public health policy,
for most major occupational or drug hazards, there
may be wide variations of opinion as to the degree
or even existence of a potential risk as determined
from experimental or in vitro data. Further, the
effectiveness of public health strategy in relation to
exposures to multiple low levels of human or animal
carcinogens is subject to uncertainty. In such cases
regulation is often ad hoc or pragmatic and tends to
be based on other certain criteria in addition to sci-
entific considerations. Where international accep-
tance is sought, the scientific data base should have
been published in the appropriate peer-reviewed
literature, although national governments, of
course, have the right to use material from any
source in making decisions.
Regulations should be feasible. Thus, they should
be acceptable, both to the general population and to
the limited segments of society to which they may
be applied. For example, where attempts have been
made to control pleasurable cultural habits, e.g.,
cigarette smoking and alcohol consumption, general
acceptance by the population has been limited,
leading to double standards in public health policy.
Regulations should be capable of being modified
with new knowledge to reduce potential conflict
with the scientific community. This flexibility
should be inherent in the regulation as originally
legislated.
Regulations should not be counterproductive, in
the sense that they distort perspectives and priori-
ties, nor should they give a false sense of security.
They should not replace a smaller hazard by a
greater risk. Thus the risk ofdying from myocardial
infarction in postmenopausal women who are not
treated with estrogens may be greater than the
risk of dying from endomentrial cancer (10). It is
also important for scientists to remember that very
minor cancer hazards shoud not be overemphasized
to the detriment of control of other health or
ecological hazards which may be of greater im-
portance to the community.
In conclusion, the above comments imply that
regulations require that the hazard and degree of
risk can be defined and measured. The important
question of risk/benefit analysis will not be dis-
cussed.
Role of Modulators in Multistage
Carcinogenesis: Implications for
Control of Generic Risks
It is necessary to classify carcinogens as geno-
toxic and nongenotoxic (11). The former group are
believed to interact directly or after activation with
cellular DNA and lead to irreversible damage to
genetic material of some magnitude. Most are
mutagens. The nongenotoxic stimuli are believed to
operate through epigenetic mechanisms and not
interact directly with cellular nucleic acids. It is
possible both types of stimuli may operate in-
directly by triggering cancer-associated genes. In
terms of the classical two-stage model, a complete
carcinogen is assumed to have both initiating and
promoting action. Some carcinogens are described
as incomplete initiators, in the sense that they lack
promoting action, and it is postulated that their ef-
fects are largely dependent on the latter. These dis-
tinctions are based largely on limited animal
models. The molecular mechanisms which basically
would distinguish incomplete from complete initia-
tion as well as the early stages of promotion from
initiators remain the subject of investigation and
conjecture especially since common mechanisms re-
main to be demonstrated between different models,
e.g., skin (12, 13) and liver (14). Furthermore, many
other factors, some of which are under genetic
control, have now been identified as modulating
cancer development in man and animals, e.g.,
procarcinogen activators or inactivators require
that a much wider conceptual base be utilized than
consideration of only initiation promotion. It is thus
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evident that the classical two-stage model, although
representing a major conceptual advance at the
time, is insufficient to explain the complex
mechanism involved in carcinogenesis including
progression.
As already mentioned, the greatest successes in
cancer prevention have been related to the identifi-
cation and control of strong carcinogenic stimuli,
e.g., alkylating agents and such cultural habits as
cigarette smoking. In some cancers, however, the
effect of a promoting agent may be so strong that it
can be identified and regarded for practical pur-
poses as a "nongenotoxic" carcinogen, in which case
preventive action may be possible, e.g., post-
menopausal estrogen medication and carcinoma of
the endometrium.
Lifestyle Cancers
Despite intensive effort, there has been compara-
tively little progress in identifying and controlling
the casual factors responsible for approximately
40% of cancers in males and 80% of those in
females. These cancers are largely those of the
gastrointestinal tract and of the endocrine or en-
docrine-dependent organs, e.g., breast, prostate,
uterus. Many of these latter have been associated
with certain carcinogenic risk factors related to
lifestyle. The term "lifestyle"-in addition to in-
cluding obvious cultural habits, e.g., cigarettes-
also covers diet, e.g., lack of fiber, and behavioral
and cultural patterns, e.g., age at first pregnancy
and degree of sexual activity. There is considerable
circumstantial evidence to indicate that such car-
cinogenic risk factors may reflect the interaction of
numerous modulating factors, e.g., enhancers,
promoters, inhibitors, enzyme activators, as well as
the milieu interieur, e.g., gastric acidity, bacterial
flora. While modulating stimuli may eventually be
defined more objectively in biochemical terms and
their relative importance evaluated, the importance
of such research in humans is only now beginning to
be recognized as discussed by Wynder (15). Where
strong initiating stimuli cannot be identified it is
possible to postulate that, while certain events
causing severe genetic damage may occur fre-
quently in man or animal, either spontaneously or
due to endogenous or exogenous exposure to
initiators, such damage is either incomplete or
lethal. Accordingly, in the former case potent en-
hancing or modulating factors would be pivotal to
cancer expression. Theoretically, such factors, if
potent and definable, could be identified and
evaluated by standard epidemiological studies.
Unfortunately, such situations are rare in humans,
and techniques to identify "spontaneously initiated"
cells in man are not available. The type of lesions,
for example as observed in latent carcinoma of the
prostate and cervical-carcinoma in situ, for example,
as compared to invasive and metastasizing cancers
is unknown. However, the existence of spontaneous
initiation is consistent with the observations of
Yuspa and Morgan (16), Haynes et al. (17), Scherer
and Emmelot (18) and others in experimental mod-
els, but its nature remains a subject for speculation.
On the one hand, it may be the equivalent of back-
ground mutation (19) and be due to failure of DNA
repair, decontrol of oncogenes, viruses, genetric
factors, etc. (11). On the other hand, it may reflect
long-term exposure of the target cell to numerous
potential initiators and mutagens, both exogenous
and endogenous-e.g., N-nitroso compounds,
epoxides of cholestrol-to which the target cell is
exposed within the body. Endogenous formation of
such compounds are now accepted as demonstrated
and are theoretically identifiable and measurable.
However, in view of the vast number of compounds
possibly involved and since the effect of each day
may be insufficient to be complete and to permit
measurement of its additive or inhibitory effect, the
possibilities of individual identification and control
in humans would appear minimal. Where cancer ex-
pression is dependent equally on numerous environ-
mental but ill defined modulating factors of very
low potency, there is no certainty that these will be
more easily identified or permit the development of
meaningful preventive strategies. Accordingly it
may be preferable to concentrate research effort on
the nature and role at the molecular level of
"spontaneous" initiation and modulating factors,
since control may prove eventually more practical
through external intervention, e.g., chemopreven-
tion based on understanding of mechanisms.
Implications for regulation
The above comments carry significant implica-
tions in developing rational legislation and regula-
tions to meet the guidelines given above. First,
where the role of a modulating factor is so predomi-
nant as to permit it to be identified and measured,
practical prevention may be possible, i.e, control of
postmenopausal estrogens and cancer of the en-
dometrium, cigarette smoking and lung cancer.
Thus, control of cigarette smoking is a base for
rational public health policy irrespective of the
relative importance of initiative or promotive effect
of cigarette smoking. On the other hand, there is
little evidence to indicate that such strong
promoting factors as DDT and phenobarbitol in the
rodent have any cancer-enhancing effect in humans,
nor that their control has had a significant impact.
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In complex situations where individual modulating
factors, although clearly associated with cancer de-
velopment cannot be measured or defined, e.g.,
types and quantity of fat, calorie intake, fiber
content, etc., generic control through legislation
would appear impossible.
Thus, in conclusion, I believe that there are at
present insufficient data to permit promulgation of
generic regulation in terms of cancer-enhancing
factors that would meet the requirements indicated
above, Further, in the immediate future it is
unlikely that such information will be obtained and
Thus decisions must be made on an ad hoc basis.
Further, it should be noted that many modulating
factors, notably hormonal and dietary, may be
important in maintaining health. This means that
consideration of such factors only in terms of cancer
and not in terms of total adverse health effects may
be imprudent (20) as for the case of postmenopausal
estrogen therapy discussed above.
Conclusion
For over 40 years the role of modulating factors
has been accepted, and it is distressing how little
additional information has been acquired that has
proven of unequivocal value in cancer prevention.
However, with more sophisticated approaches both
in the laboratory and in the field, it may now be
feasible to study the modulating aspects of car-
cinogenesis more effectively. Nonetheless, in
examining the role of epidemiology in this field, we
could find only mention of"promotion" in six of over
1300 studies described in the 1981 IARC Directory
of ongoing epidemiological research. This would
suggest that this area is being inadequately studied
or that epidemiologists are considering "carcino-
genic risk factors" in a much wider context than the
classical two-stage model.
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